Cerus (CERS) Tops Q4 EPS by 1c

Go back to Cerus (CERS) Tops Q4 EPS by 1c

Cerus Corporation Reports Record Fourth Quarter and Year End 2017 Results

March 8, 2018 4:03 PM EST

CONCORD, Calif.--(BUSINESS WIRE)-- Cerus Corporation (Nasdaq: CERS) today announced financial results for the fourth quarter and year ended December 31, 2017.

Recent developments and highlights include:

Reported record fourth quarter product revenue of $16.2 million, an increase of 60% compared to the same period in the year prior. Established 2018 annual product revenue guidance of $51 million to $53 million, which would represent a 17% to 22% increase over 2017 reported product revenue. Successfully met primary safety and efficacy endpoints in SPARC, Cerus European Phase 3 clinical trial evaluating INTERCEPT red cell... More